Does chronic systemic inflammation cause lower testosterone and poorer semen quality?

Chronic systemic inflammation is a significant driver of male reproductive decline, acting as a bridge between metabolic health and functional hypogonadism. In aging men, this state of persistent low-grade immune activation—often termed "inflammaging"—directly interferes with the hormonal and cellular environments necessary for optimal testosterone production and sperm development.

Clinical evidence for functional hypogonadism

Large-scale population studies, including data from the National Health and Nutrition Examination Survey (NHANES), have established a robust inverse relationship between systemic inflammation and testosterone levels.

• Inflammatory Indices: Higher scores on the Systemic Immune-Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI) are strongly correlated with an increased risk of testosterone deficiency (defined as <300 ng/dL). Men in the highest quartiles of these indices often show significantly lower total and free testosterone levels.
• C-Reactive Protein (CRP): Elevated high-sensitivity CRP (hs-CRP) serves as a reliable predictor of secondary hypogonadism, where the hormonal deficiency is driven by comorbid inflammatory states rather than primary testicular failure.

Impact on semen parameters and fertility

Systemic inflammation exerts a deleterious effect on the microenvironment of the testes, leading to measurable declines in fertility markers.

• Semen Quality: High levels of systemic inflammatory markers are associated with reductions in sperm concentration, motility, and vitality. Research indicates that even in the absence of localized infection, systemic cytokines like IL-6 and TNF-α correlate with poor morphology and higher rates of leukocytospermia.
• DNA Integrity: Chronic inflammation is a primary catalyst for increased sperm DNA fragmentation (SDF). This occurs when the inflammatory burden exceeds the seminal antioxidant capacity, leading to structural damage that can result in subfertility or recurrent pregnancy loss.

Mechanistic explanations

The link between inflammatory burden and reproductive dysfunction is mediated by complex cytokine signaling and oxidative stress.

• HPT Axis Suppression: Pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) suppress the hypothalamic-pituitary-testicular (HPT) axis. They inhibit the pulsatile release of Gonadotropin-Releasing Hormone (GnRH) and Luteinizing Hormone (LH), effectively "turning down" the central signal for testosterone production.
• Leydig Cell Dysfunction: Within the testes, these cytokines directly impair Leydig cell steroidogenesis. They downregulate steroidogenic enzymes and the Steroidogenic Acute Regulatory (StAR) protein, which is essential for cholesterol transport into the mitochondria for testosterone synthesis.
• Blood-Testis Barrier (BTB) Disruption: Systemic inflammation can compromise the integrity of the blood-testis barrier. When this barrier is weakened, inflammatory mediators and reactive oxygen species (ROS) gain access to the seminiferous tubules, triggering germ cell apoptosis and disrupting the tight junctions of Sertoli cells necessary for healthy spermatogenesis.

Bottom line

Chronic systemic inflammation is a scientifically validated cause of functional hypogonadism and impaired semen quality. By suppressing the HPT axis and inducing oxidative stress within the testicular microenvironment, inflammatory burden significantly reduces testosterone synthesis and compromises sperm DNA integrity, leading to subfertility. Managing systemic inflammation through lifestyle or clinical interventions remains a critical strategy for restoring male reproductive health.